Overview
Lobbying Costs
150,000€
Financial year: Jan 2016 - Dec 2016
Lobbyists (Full time equivalent)
0.75 Fte (3)
Lobbyists with EP accreditation
3
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Ipsen Pharma
EU Transparency Register
84295189159-07 First registered on 15 Jul 2012
Goals / Remit
Ipsen is a global specialty-driven pharmaceutical group. Our ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Our fields of expertise cover oncology, neurosciences and endocrinology.
Main EU files targeted
Human healthcare
Research in lifesciences
Social affairs
Enterprise
CompetitivenessAddress
Head Office
65, quai Georges Gorse
Boulogne-Billancourt 92650
FRANCE -
People
Total lobbyists declared
3
Employment time Lobbyists 25% 3 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 21 Apr 2017
Name Start date End Date Loubna Ouriaghli 15 Nov 2023 14 Nov 2024 Ms Loubna Ouriaghli 15 Nov 2023 15 Apr 2024 Ms Loubna Ouriaghli 18 Oct 2022 14 Oct 2023 Ms Heloise LEVALLOIS 14 Sep 2019 12 Sep 2020 Mr Jan SWIDERSKI 24 May 2018 24 May 2019 Ms Heloise LEVALLOIS 28 Apr 2018 27 Apr 2019 Ms Heloise LEVALLOIS 15 Sep 2016 15 Sep 2017 Mr Giovanni Asta 06 Sep 2016 07 Sep 2017 Mr Jan SWIDERSKI 05 Sep 2016 01 Sep 2017 Ms Heloise LEVALLOIS 10 Sep 2015 08 Sep 2016 Mr Giovanni Asta 17 Jul 2015 15 Jul 2016 Mr Jan SWIDERSKI 17 Jul 2015 15 Jul 2016 Mr Giovanni Asta 05 Jul 2014 03 Jul 2015 Mr Jan SWIDERSKI 28 Jun 2014 26 Jun 2015 Complementary Information
3 IPSEN employees spend less than 10% of their time on activities.
Person in charge of EU relations
Mr Giovanni Asta (Public Affairs Director Ipsen Group)
Person with legal responsibility
Mr David D. Meek (CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Ipsen Pharma is a member of the following organisations
- EFPIA
- EBE
- ChemLegMember organisations
N/A
-
Financial Data
Closed financial year
Jan 2016 - Dec 2016
Lobbying costs for closed financial year
150,000€
Other financial info
This estimate follows EFPIA guidelines.
It includes
- a percentage of the average FTE for colleagues whose activities fall under the scope of the Register (salaries + other costs),
- a percentage of the overall travel costs,
- the cost of all activities performed by external providers (consultancies) that fall under the scope of the register,
- a proportion of Trade associations membership fees, as per EFPIA guidelines. -
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
N/A
Other activities
Marc de Garidel, President of the Board, co-chaired the IMI Governing Board in 2015-2017.
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 29 Nov 2017 Location Brussels Subject Pharmaceutical incentives, antimicrobial resistance Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists
- Meetings